Factors involved in the inhibition of drug metabolism by (-)-emetine.
D000632:Aminopyrine / Q000378:metabolism*; D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D001391:Azo Compounds / Q000378:metabolism; D002248:Carbon Monoxide / Q000494:pharmacology; D003580:Cytochromes / Q000378:metabolism; D003640:Dealkylation; D004640:Emetine / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D007700:Kinetics; D015122:Mercaptopurine / Q000378:metabolism*; D008660:Metabolism / Q000187:drug effects; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D009019:Morphinans / Q000378:metabolism*; D009249:NADP; D009584:Nitrogen / Q000494:pharmacology; D009705:Nucleosides / Q000378:metabolism*; D010088:Oxidoreductases / Q000378:metabolism; D051381:Rats; D012263:Ribonucleosides / Q000378:metabolism; D013778:Tetrazolium Salts
D000814:Aniline Compounds; D001391:Azo Compounds; D003580:Cytochromes; D009019:Morphinans; D009705:Nucleosides; D012263:Ribonucleosides; D013778:Tetrazolium Salts; D000632:Aminopyrine; D009249:NADP; D002248:Carbon Monoxide; D015122:Mercaptopurine; D010088:Oxidoreductases; D009584:Nitrogen; D004640:Emetine